| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |